Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 16,981–17,000 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test cyp 35 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test Cyp 25 mg-e(2) blend 12 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test cyp 25 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test cyp 25 mg-Estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test cyp 25 mg-Estadiol valerate 15 mg/mL, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test Cyp 200 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Sodium Chloride (23.4%), Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Progesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine-cyclopentolate, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Pap 300 mg-phent 10 mg-prost 100 mcg, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Ophthalmic dilation gel (MAR), Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Ophthalmic dilation gel, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin (modified) 0.02% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin 0.04% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiated
March 20, 2013
Reported by FDA
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.